Tinea
Drug research and approvals for tinea: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 17, 2026, 16 studies of tinea are recruiting on ClinicalTrials.gov, and Health Canada has authorized 1 drug trials for it since 2013.
- Recruiting worldwide: 16
- Trials authorized in Canada: 1
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 16 recruiting on ClinicalTrials.gov ↗- In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates…NCT07898475 · Not reported · Dr. Amara Safdar · starts Oct 2, 2026
- Topical Lactoferrin and Luliconazole, Alone or in Combination, for Tinea CorporisNCT07937020 · Not applicable · Kafrelsheikh University · starts Sep 1, 2026
- A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by DermatophytesNCT07668999 · Phase 1 · Sinomune Pharmaceutical Co., Ltd · starts Jul 21, 2026
- URGO MICKAEL Filmogel, Topical Treatment of OnychomycosisNCT07828184 · Not applicable · CEN Biotech · starts Jan 28, 2026
- A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With…NCT07312604 · Not applicable · Abeer Mohamed Abdelaziz Elkholy · starts Dec 9, 2025
- Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea CorporisNCT07342153 · Phase 4 · Urooj Fatima · starts Nov 1, 2025
- Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea PedisNCT07056660 · Not applicable · Shenyang Medical College · starts Jul 25, 2025
- Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in ChildrenNCT07184203 · Not applicable · Alexandria University · starts Mar 9, 2025
- Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis VersicolorNCT06922344 · Phase 4 · Khyber Teaching Hospital · starts Mar 1, 2025
- A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea VersicolorNCT05730244 · Phase 1 · The University of The West Indies · starts Mar 1, 2025
Drug Pipeline
10 approved; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Ketoconazole, Butenafine, Terbinafine, Griseofulvin, Clotrimazole, Miconazole, Oxiconazole, Selenium sulfide, Luliconazole, Tolnaftate
How Its Trials Ended
80 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 12 whose ending is known, 50% met their primary endpoint, 0% missed it and 50% stopped early.
- Completed, result not reported5974%
- Status unknown810%
- Met its primary endpoint68%
- Stopped: other or unclear34%
- Stopped: lack of efficacy23%
- Ongoing11%
- Stopped: enrollment or feasibility11%
Trials Authorized in Canada
Newest first; search them all in Canada trials| Authorized | Trial | Sponsor | Status |
|---|---|---|---|
| Jun 29, 2016 | A blinded placebo controlled clinical trial to evaluate fungicidal activity with the topical application of nitric oxide releasing solution (nors) in subjects…Nitric oxide releasing solution | Nitric Solutions Inc | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA